Our L. Gasseri & SlimBiotics® supplement is a synergistic probiotic formula featuring the Lactobacillus gasseri strain CNCM I-5076 and the patented SlimBiotics® probiotic blend.*
This supplement brings together strains that might have been studied for their potential to support gut microbiota diversity and overall metabolic well-being.*
It is part of our Slimming and Weight Management product category.*
Lactobacillus Gasseri, SlimBiotics®, and Metabolic Support*
This dual-action formula combines two probiotic strains:*
- Lactobacillus gasseri CNCM I-5076 is a species of lactic acid bacteria that may be studied for its potential role in maintaining gut microbiota balance and digestive comfort.* Research appears to have explored its possible influence on factors related to body composition and metabolic processes.* This strain may also have been examined for its interaction with metabolic signals related to appetite and energy use, as well as its probable involvement in fat metabolism pathways.* The CNCM I-5076 strain was selected for this formula due to its documentation.*
- SlimBiotics® is a plant-based probiotic blend developed by the Austrian company SlimBiotics.* It is composed of three Lactobacillus fermentum strains (K7-Lb1, K8-Lb1, K11-Lb3), naturally sourced from kimere, a fermented pearl millet porridge that may be traditionally consumed by the Mbeere community in Kenya.* This patented complex appears to have been formulated to help support gut microbiota balance, as well as metabolic health, as explored in a double-blind, randomized, placebo-controlled clinical study on individuals with specific body composition characteristics.* It may also have been studied for its potential influence on metabolic markers and digestive balance.*
Three Potential Features of L. Gasseri & SlimBiotics® for Metabolic Support*
Our L. Gasseri & SlimBiotics® probiotic supplement features 3 main characteristics, potentially making it a good supplement choice:*
- Dual probiotic synergy: combines Lactobacillus gasseri with the proprietary SlimBiotics® blend, offering a potentially complementary microbial support.*
- Dosage based on research: delivers 12 billion CFU of L. gasseri and 6 billion CFU of SlimBiotics® daily, striving to reflect amounts tested in scientific studies.*
- Targeted delivery system: features gastro-resistant capsules designed to help probiotics reach the gut intact, encouraging their effectiveness.*
Reminder: research suggests that a balanced gut microbiota might play a role in the way the body processes nutrients and maintains energy equilibrium.* Supporting this balance with probiotics may be a helpful addition to your daily routine and an important factor in overall well-being.*
WARNINGS
Do not exceed the recommended daily dose. This product is a nutritional supplement and should not be used as a substitute for a varied and balanced diet or a healthy lifestyle.
STORAGE
Store in a cool, dry place away from direct sunlight, heat, and humidity.
Keep out of reach of children.
PREGNANCY AND MEDICAL CONDITIONS
If you are pregnant, breastfeeding, or have any medical conditions, consult your healthcare provider before using this product.
SUPPLEMENT INTERACTIONS
Consult your healthcare provider before use, especially if you are taking any medications or other supplements as there may be potential interactions.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Daily dose: 2 capsules
Number of doses per pack: 30
| Amount per dose |
Lactobacillus gasseri CNCM I-5076
| 12x109 CFU |
SlimBiotics®
Lactobacillus fermentum K7-Lb1
Lactobacillus fermentum K8-Lb1
Lactobacillus fermentum K11-Lb3 |
6x109 CFU |
Other ingredient: acacia gum.
SlimBiotics® is a registered trademark of SlimBiotics GmbH.
|
Take 2 capsules per day, 30 minutes before a meal.
30 days.
Better kept refrigerated.
As with all nutritional supplements, consult a health professional before taking this supplement. Not recommended for pregnant or breastfeeding women or those with a potential health concern.*
For adults only. Do not exceed the recommended daily dose. This product is a dietary supplement and should not be used as a substitute for a varied, balanced diet and a healthy lifestyle. Keep out of children’s reach.
- Álvarez-Arraño V, Martín-Peláez S. Effects of Probiotics and Synbiotics on … : A Systematic Review. Nutrients. 2021 Oct 17;13(10):3627. doi: 10.3390/nu13103627. PMID: 34684633; PMCID: PMC8540110.
- Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on … : A Randomized, Double-Blind Clinical Trial. Korean J Fam Med. 2013 Mar;34(2):80-9. doi: 10.4082/kjfm.2013.34.2.80. Epub 2013 Mar 20. PMID: 23560206; PMCID: PMC3611107.
- Kim J, Yun JM, Kim MK, Kwon O, Cho B. Lactobacillus gasseri BNR17 Supplementation … : A Randomized, Double-Blind, Placebo-Controlled Trial. J Med Food. 2018 May;21(5):454-461. doi: 10.1089/jmf.2017.3937. Epub 2018 Apr 24. PMID: 29688793.
- Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. … Lactobacillus gasseri BNR17 in … . PLoS One. 2013;8(1):e54617. doi: 10.1371/journal.pone.0054617. Epub 2013 Jan 30. PMID: 23382926; PMCID: PMC3559800.
- https://www.nutraingredients-usa.com/Article/2023/07/10/SlimBiotics-on-plant-based-probiotic-for-...
- Laue, C.; Papazova, E.; Pannenbeckers, A.; Schrezenmeir, J. Effect of a Probiotic and a Synbiotic on … : A Human, Double-Blind, Randomised, Controlled Clinical Study. Nutrients 2023, 15, 3039. https://doi.org/10.3390/nu15133039.
- Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on … : A Randomized, Double-Blind Clinical Trial. Korean J Fam Med. 2013 Mar;34(2):80-9. doi: 10.4082/kjfm.2013.34.2.80. Epub 2013 Mar 20. PMID: 23560206; PMCID: PMC3611107.
- Miyoshi M, Ogawa A, Higurashi S, Kadooka Y. … of Lactobacillus gasseri SBT2055 accompanied by … . Eur J Nutr. 2014;53(2):599-606. doi: 10.1007/s00394-013-0568-9. Epub 2013 Aug 6. PMID: 23917447.
- de Moura E Dias M, da Silva Duarte V, Mota LFM, de Cássia Ávila Alpino G, Dos Reis Louzano SA, da Conceição LL, Mantovanie HC, Pereira SS, Oliveira LL, de Oliveira Mendes TA, Porcellato D, do Carmo Gouveia Peluzio M. 2023 Mar 3;12(5):1092. doi: 10.3390/foods12051092. PMID: 36900609; PMCID: PMC10001121.